56.50
0.92%
0.428
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRNX Giù?
Forum
Previsione
Crinetics Pharmaceuticals Inc Azioni (CRNX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
0.64
|
- | 0.346 | 0.988 | 2.679 |
Operating Expenses
|
18.37%
74.17
|
62.66 | 59.32 | 53.98 | 50.66 |
Benefits Costs and Expenses |
100.00%
-
|
218.54 | - | - | - |
Costs And Expenses |
35.89%
74.17
|
54.58 | 59.32 | 53.98 | 50.66 |
Depreciation and Amortization |
80.92%
0.474
|
0.262 | 0.273 | 0.28 | 0.283 |
Operating Income/Loss |
17.35%
-73.53
|
-62.66 | -58.98 | -52.99 | -47.98 |
Nonoperating Income/Loss |
4.54%
7.069
|
6.762 | 2.516 | 2.016 | 1.983 |
Income/Loss From Continuing Operations Before Tax |
100.29%
0.64
|
-218.54 | 0.346 | 0.988 | 2.679 |
Income/Loss From Continuing Operations After Tax |
11.37%
-66.93
|
-60.10 | -57.46 | -50.98 | -45.99 |
Net Income/Loss
|
11.37%
-66.93
|
-60.10 | -57.46 | -50.98 | -45.99 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2,256%
72.29
|
3.068 | 56.81 | 54.27 | 53.91 |
Diluted Average Shares |
2,256%
72.29
|
3.068 | 56.81 | 54.27 | 53.91 |
Basic Earnings Per Share |
5.68%
-0.93
|
-0.88 | -1.01 | -0.94 | -0.85 |
Diluted Earnings Per Share |
5.68%
-0.93
|
-0.88 | -1.01 | -0.94 | -0.85 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):